Hoxworth Blood Center rounds out Cincinnati Favorites blood drive tour at neighborhood donor centers
As the hugely popular Cincinnati Favorites Summer Blood Drive Tour comes to an end, Hoxworth Blood Center is giving donors one last chance to score their limited-edition t-shirt and a special gift from local sponsors.
Eligible individuals are invited to donate blood or platelets at one of seven Hoxworth Neighborhood Donor Centers during Cincinnati Favorites week, scheduled for Tuesday, Sept. 8 through Monday, Sept. 14.
During the Cincinnati Favorites blood drive tour, Hoxworth teamed up with local restaurants like Skyline Chili, Frisch’s, Graeter’s Ice Cream, Busken Bakery, Coffee Emporium, LaRosa’s, Montgomery Inn, Taste of Belgium, Aglamesis Bros. and The BonBonerie for a series of blood drives held throughout the summer. Donors received a “Cincinnati Favorites” t-shirt and a special gift from drive sponsors.
Donors who give during Cincinnati Favorites week will receive the exclusive t-shirt, as well as gift from participating sponsors while supplies last.
“This year’s Cincinnati Favorites tour has been hugely popular, even as the COVID-19 pandemic posed unique challenges for our staff and donors,” says Alecia Lipton, Hoxworth spokesperson. “Partnering with these uniquely Cincinnati businesses has been a great way to support local restaurants and save lives in the process.”
Appointments are highly encouraged. Donors can schedule appointments by calling (513) 451-0910 or by scheduling online at https://hoxworth.org/donors/locations.html.
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati was founded in 1938 and serves over 30 hospitals and medical facilities in Ohio, Kentucky and Indiana. Hoxworth collects blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center. All Types Welcome.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.